Last reviewed · How we verify

NCT04229082

Next Generation Probiotics (NGPs) for Metabolic Health

Completed Last updated 27 January 2020
What this trial tests

trial testing observational in Microbial Colonization in 100 participants. Completed in 9 June 2017.

Timeline
8 April 2016
Primary endpoint
1 October 2016
9 June 2017

Quick facts

Lead sponsorDanisco
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date8 April 2016
Primary completion1 October 2016
Estimated completion9 June 2017

Drugs / interventions tested

Conditions studied

Sponsor

Danisco — full company profile →

Who can join

Adults 20 to 50, female only, with Microbial Colonization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To identify differences in the intestinal microbiota by metagenomics analyses between lean and obese subjects

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. <i>Akkermansia</i> beyond muciniphila - emergence of new species <i>Akkermansia massiliensis</i> sp. nov.
    Kumar R, Hasselwander O, Kane H, Hibberd AA. · · 2024 · cited 3× · PMID 39421258 · DOI 10.20517/mrr.2024.28
  2. Safety evaluation of &lt;i&gt;Akkermansia massiliensis&lt;/i&gt; sp. nov. DSM 33459.
    Pitt J, Bauter MR, Kumar R, Hasselwander O, et al · · 2025 · PMID 40491581 · DOI 10.1016/j.toxrep.2025.102042

Verify or expand the search:

Other trials of observational

Trials testing the same drug.

Other recruiting trials for Microbial Colonization

Currently open trials in the same condition.

Other Danisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04229082.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing